BioIntelliSense

BioIntelliSense's Medical Grade Remote Care Solutions

BioIntelliSense specializes in providing medical grade remote care solutions that span from in-hospital settings to home care environments. Their innovative approach is centered around continuous monitoring of vital signs through advanced wearable technology. This ensures that healthcare providers can maintain a close watch on patient health metrics, thereby enhancing the quality of care and enabling timely interventions. The scalability of their solutions allows for seamless integration across various care settings, making them a crucial player in the evolving landscape of remote healthcare.

BioIntelliSense's BioButton

The BioButton by BioIntelliSense is a multi-parameter wearable device designed for continuous monitoring of vital signs. This medical grade device provides real-time data on a patient's physiological status, including temperature, heart rate, and respiratory rate. The BioButton's capacity for continuous monitoring is critical for early detection of potential health issues, enabling healthcare providers to intervene promptly. Its discreet and user-friendly design makes it suitable for use in both hospital and home settings, ensuring continuous care and monitoring regardless of the patient's location.

BioIntelliSense's Partnership with Medtronic

In a strategic move to enhance the distribution of their BioButton medical grade wearables, BioIntelliSense has formed a partnership with Medtronic, a global leader in medical technology. This collaboration aims to distribute BioButton devices across U.S. hospitals, significantly expanding their reach and impact. Medtronic's extensive network and established presence in the healthcare sector provide a robust platform for BioIntelliSense to scale its innovative solutions, thereby improving patient monitoring and healthcare outcomes on a broader scale.

BioIntelliSense's Acquisition of AlertWatch

To bolster their patient monitoring solutions, BioIntelliSense acquired AlertWatch, a clinical intelligence engine known for its advanced data analytics capabilities. This acquisition enables BioIntelliSense to integrate high-frequency vital sign trending and reporting into their suite of products. The enhanced data analytics provided by AlertWatch empowers healthcare providers with actionable insights, facilitating better clinical decision-making and patient management. This strategic acquisition underscores BioIntelliSense's commitment to leveraging cutting-edge technology to improve healthcare delivery.

BioIntelliSense's Series B Financing Round

BioIntelliSense successfully closed an oversubscribed $45 million Series B financing round, aimed at scaling its Data-as-a-Service and clinical intelligence platform. This significant infusion of capital will be utilized to expand their technological infrastructure, accelerate product development, and enhance their market presence. The successful financing round reflects strong investor confidence in BioIntelliSense's innovative solutions and their potential to transform remote patient monitoring and healthcare analytics. The funds will further support the company's mission to provide continuous medical grade monitoring across diverse care settings.